Predicting Malignancy in Pediatric Thyroid Nodules: Early Experience With Machine Learning for Clinical Decision Support

Author:

Radebe Lebohang12ORCID,van der Kaay Daniëlle C M3,Wasserman Jonathan D45ORCID,Goldenberg Anna1267ORCID

Affiliation:

1. Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada

2. Department of Computer Science, University of Toronto, Toronto, Ontario, Canada

3. Erasmus Medical Center - Sophia Children’s Hospital, Rotterdam CB, the Netherlands

4. Division of Endocrinology, The Hospital for Sick Children, Toronto, Ontario, Canada

5. Department of Paediatrics, Faculty of Medicine, The University of Toronto, Ontario, Canada

6. Vector Institute, Toronto, Ontario, Canada

7. CIFAR, Toronto, Ontario, Canada

Abstract

Abstract Objective To develop a machine learning tool to integrate clinical data for the prediction of non-benign thyroid cytology and histology. Context Papillary thyroid carcinoma is the most common endocrine malignancy. Since most nodules are benign, the challenge for the clinician is to identify those most likely to harbor malignancy while limiting exposure to surgical risks among those with benign nodules. Methods Random forests (augmented to select features based on our clinical measure of interest), in conjunction with interpretable rule sets, were used on demographic, ultrasound, and biopsy data of thyroid nodules from children younger than 18 years at a tertiary pediatric hospital. Accuracy, false-positive rate (FPR), false-negative rate (FNR), and area under the receiver operator curve (AUROC) are reported. Results Our models predict nonbenign cytology and malignant histology better than historical outcomes. Specifically, we expect a 68.04% improvement in the FPR, 11.90% increase in accuracy, and 24.85% increase in AUROC for biopsy predictions in 67 patients (28 with benign and 39 with nonbenign histology). We expect a 23.22% decrease in FPR, 32.19% increase in accuracy, and 3.84% decrease in AUROC for surgery prediction in 53 patients (42 with benign and 11 with nonbenign histology). This improvement comes at the expense of the FNR, for which we expect 10.27% with malignancy would be discouraged from performing biopsy, and 11.67% from surgery. Given the small number of patients, these improvements are estimates and are not tested on an independent test set. Conclusion This work presents a first attempt at developing an interpretable machine learning based clinical tool to aid clinicians. Future work will involve sourcing more data and developing probabilistic estimates for predictions.

Funder

Garron Family Cancer Centre

Canadian Institutes of Health Research

Natural Sciences and Engineering Research Council of Canada

Canadian Institute for Advanced Research

Genome Canada

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3